1. Home
  2. RFL vs GROV Comparison

RFL vs GROV Comparison

Compare RFL & GROV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RFL
  • GROV
  • Stock Information
  • Founded
  • RFL 2017
  • GROV 2016
  • Country
  • RFL United States
  • GROV United States
  • Employees
  • RFL N/A
  • GROV N/A
  • Industry
  • RFL Real Estate
  • GROV Package Goods/Cosmetics
  • Sector
  • RFL Finance
  • GROV Consumer Discretionary
  • Exchange
  • RFL Nasdaq
  • GROV Nasdaq
  • Market Cap
  • RFL 65.4M
  • GROV 59.0M
  • IPO Year
  • RFL N/A
  • GROV N/A
  • Fundamental
  • Price
  • RFL $2.01
  • GROV $1.33
  • Analyst Decision
  • RFL
  • GROV Buy
  • Analyst Count
  • RFL 0
  • GROV 1
  • Target Price
  • RFL N/A
  • GROV $2.00
  • AVG Volume (30 Days)
  • RFL 41.9K
  • GROV 242.6K
  • Earning Date
  • RFL 03-12-2025
  • GROV 03-05-2025
  • Dividend Yield
  • RFL N/A
  • GROV N/A
  • EPS Growth
  • RFL N/A
  • GROV N/A
  • EPS
  • RFL N/A
  • GROV N/A
  • Revenue
  • RFL $697,000.00
  • GROV $213,781,000.00
  • Revenue This Year
  • RFL N/A
  • GROV N/A
  • Revenue Next Year
  • RFL N/A
  • GROV $0.84
  • P/E Ratio
  • RFL N/A
  • GROV N/A
  • Revenue Growth
  • RFL 151.62
  • GROV N/A
  • 52 Week Low
  • RFL $1.29
  • GROV $1.19
  • 52 Week High
  • RFL $2.50
  • GROV $2.44
  • Technical
  • Relative Strength Index (RSI)
  • RFL 58.35
  • GROV 44.41
  • Support Level
  • RFL $1.83
  • GROV $1.32
  • Resistance Level
  • RFL $2.01
  • GROV $1.95
  • Average True Range (ATR)
  • RFL 0.15
  • GROV 0.13
  • MACD
  • RFL 0.02
  • GROV -0.02
  • Stochastic Oscillator
  • RFL 94.44
  • GROV 6.06

About RFL Rafael Holdings Inc. Class B

Rafael Holdings Inc is a holding company with interests in clinical and early-stage pharmaceutical companies. Its primary focus is to expand its investment portfolio through opportunistic investments including therapeutics, which address high unmet medical needs. Through the companies it has invested in, the company is focused on; developing Trappsol Cyclo its clinical program, developing instruments to advance minimally invasive surgeries, preclinical cancer metabolism research operations, and developing pharmaceutical-grade technology Unlokt for third-party cannabis manufacturers. It also holds and manages commercial real estate assets in Jerusalem, Israel. The company's reportable segments are; Infusion Technology, which derives maximum revenue, Healthcare, and Real Estate.

About GROV Grove Collaborative Holdings Inc.

Grove Collaborative Holdings Inc is engaged in providing consumer products. It offers Cleaning accessories, Home and Pantry, Personal care products, Pets supplements and Other products.

Share on Social Networks: